Research ArticleTECHNOLOGY/APPLICATION
A Consensus Rating Method for Small Virus-Retentive Filters. I. Method Development
Scott Lute, William Riordan, Leonard F. Pease, De-Hao Tsai, Richard Levy, Mohammed Haque, Jerold Martin, Ichiro Moroe, Terry Sato, Michael Morgan, Mani Krishnan, Jennifer Campbell, Paul Genest, Sherri Dolan, Klaus Tarrach, Anika Meyer, The PDA Virus Filter Task Force, Michael R. Zachariah, Michael J. Tarlov, Mark Etzel and Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology September 2008, 62 (5) 318-333;
Scott Lute
William Riordan
Leonard F. Pease III
De-Hao Tsai
Richard Levy
Mohammed Haque
Jerold Martin
Ichiro Moroe
Terry Sato
Michael Morgan
Mani Krishnan
Jennifer Campbell
Paul Genest
Sherri Dolan
Klaus Tarrach
Anika Meyer
Michael R. Zachariah
Michael J. Tarlov
Mark Etzel
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 62, Issue 5
September/October 2008
A Consensus Rating Method for Small Virus-Retentive Filters. I. Method Development
Scott Lute, William Riordan, Leonard F. Pease, De-Hao Tsai, Richard Levy, Mohammed Haque, Jerold Martin, Ichiro Moroe, Terry Sato, Michael Morgan, Mani Krishnan, Jennifer Campbell, Paul Genest, Sherri Dolan, Klaus Tarrach, Anika Meyer, The PDA Virus Filter Task Force, Michael R. Zachariah, Michael J. Tarlov, Mark Etzel, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2008, 62 (5) 318-333;
A Consensus Rating Method for Small Virus-Retentive Filters. I. Method Development
Scott Lute, William Riordan, Leonard F. Pease, De-Hao Tsai, Richard Levy, Mohammed Haque, Jerold Martin, Ichiro Moroe, Terry Sato, Michael Morgan, Mani Krishnan, Jennifer Campbell, Paul Genest, Sherri Dolan, Klaus Tarrach, Anika Meyer, The PDA Virus Filter Task Force, Michael R. Zachariah, Michael J. Tarlov, Mark Etzel, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology Sep 2008, 62 (5) 318-333;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal
- Bioprocess: Robustness with Respect to Mycoplasma Species
- Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration
- Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses
- Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies